Pleural Effusion, Malignant - 25 Studies Found
Recruiting |
: Bevacizumab in the Treatment of Malignant Pleural Effusions of Non-squamous Non-small Cell Lung Cancer : Malignant Pleural Effusion : 2016-10-18 : Drug: Bevacizumab Group A (low dose group) Intrapleural in |
Completed |
: A Quality of Life Study re Management of Malignant Pleural Effusions : Malignant Pleural Effusions : 2005-09-12 : Behavioral: LCADLS, FACIT-PAL, FACIT-TS questionnaires LCADLS, FACIT-PAL, FACIT-TS questionnaires |
Recruiting |
: Using Thoracic Ultrasound to Predict Pleurodesis Success in Malignant Pleural Effusions: a Pilot Study : Malignant Pleural Effusion : 2015-10-21 : Other: Ultrasound scan |
Recruiting |
: Efficacy and Safety of Bevacizumab Versus Pulvis Talci in Malignant Pleural Effusion : Malignant Pleural Effusion : 2014-01-28 :
|
Completed |
: Efficacy and Safety Study of Abnoba Viscum F 20mg in Malignant Pleural Effusion Patients : Malignant Pleural Effusion : 2014-07-14 : Drug: Abnoba Viscum F 20mg intravesical instillation of five amples of AbnobaViscum® F20mg and 0.9% |
Recruiting |
: A Study to Compare the Efficacy and Safety of Intrapleural Doxycycline Versus Iodopovidone for Performing Pleurodesis in Malignant Pleural Effusion : Malignant Pleural Effusion : 2015-08-04 :
|
Completed |
: Talc Pleurodesis in Patients With Recurrent Malignant Pleural Effusion : Recurrent Malignant Pleural Effusion. : 2008-11-10 :
|
Completed |
: Intrapleural Bevacizumab and Cisplatin Therapy for Malignant Pleural Effusion Caused by Non-small Cell Lung Cancer : Malignant Pleural Effusion : 2012-07-25 :
|
Recruiting |
: A Clinical Study Evaluating the Safety and Effectiveness of a New Pleural Catheter for the Medical Management of Symptomatic, Recurrent, Malignant Pleural Effusions Compared to Approved Pleural Catheter. : Malignant Pleural Effusion : 2015-12-18 : Device: Indwelling Pleural Catheter |
Terminated |
: Zometa Adjuvant Treatment of Malignant Pleural Effusion Due To Non-Small Cell Lung Cancer :
: Drug: zoledronic acid Zoledronic acid (Zometa) 4mg IV every 4 weeks for 3 treatments with chemotherapy a |